Oral iron chelating agents: improving quality of life in transfusion-dependent thalassemia
Maria Domenica Cappellini • 14 Jun 2018
Next steps in VTE treatment: will oral edoxoban replace the current standard of care?
Harry Buller • 10 Dec 2017
Promising results in MDS for ASTX727, an oral decitabine and cytidine deaminase inhibitor agent
Guillermo Garcia-Manero • 9 Dec 2017